Search results :

Cefixime

More information: STITCH, PubChem (stereo-specific compounds: 1, 2) and possibly Wikipedia

ATC Code: J01DD08

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3
Diarrhoea Diarrhoea 15% - 16% x x x
Loose stools 6% x x
Nausea Nausea 7% - 9% x x x
Abdominal pain Abdominal pain 3% - 5% x x x
Gastrointestinal pain Abdominal pain 3% - 5% x x x
Dyspepsia Dyspepsia 3% x x x
Flatulence Flatulence 3% x x x
Vomiting Vomiting 2% x x x
Agranulocytosis Agranulocytosis postmarketing x x x
Aplastic anaemia Aplastic anaemia postmarketing x x x
Haemolytic anaemia Haemolytic anaemia postmarketing x x x
Angioedema Angioedema postmarketing x x x
Candida infection Candida infection postmarketing x x x
Cholestasis Cholestasis postmarketing x x x
Colitis Colitis postmarketing x x
Dizziness Dizziness postmarketing, 3% x x x
Eosinophilia Eosinophilia postmarketing x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x x x
Erythema multiforme Erythema multiforme postmarketing x x x
Stevens-Johnson syndrome postmarketing x x x
Dermatitis Rash postmarketing x x x
Rash Rash postmarketing x x x
Headache Headache postmarketing, 11% x x x
Haemorrhage Haemorrhage postmarketing x x x
Haemoglobin Haemorrhage postmarketing x x x
Hepatitis Hepatitis postmarketing x x
Hyperbilirubinaemia Hyperbilirubinaemia postmarketing x x
Hypersensitivity Hypersensitivity postmarketing x x x
Jaundice Jaundice postmarketing x x
Renal failure acute Renal failure acute postmarketing x x
Leukopenia Leukopenia postmarketing x x x
Neutropenia Neutropenia postmarketing x x x
Pancytopenia Pancytopenia postmarketing x x x
Pruritus Pruritus postmarketing x x x
Pruritus genital Pruritus genital postmarketing x x x
Convulsion Convulsion postmarketing x x x
Serum sickness Serum sickness postmarketing x x
Shock Shock postmarketing x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x
Superinfection Superinfection postmarketing x x x
Thrombocytopenia Thrombocytopenia postmarketing x x x
Urticaria Urticaria postmarketing x x x
Vaginal inflammation Vaginal inflammation postmarketing x x x
Vaginal infection Vaginal inflammation postmarketing x x x
Hepatic function abnormal Hepatic function abnormal postmarketing x x x
Blood lactate dehydrogenase increased Lactic dehydrogenase activity increased postmarketing x x x
Anaphylactic shock Anaphylactoid reaction postmarketing x x
Anaphylactic shock x
Anaphylactoid reaction Anaphylactoid reaction postmarketing x x
Face oedema Face oedema postmarketing x x
Nephropathy toxic Nephropathy toxic postmarketing x x x
Pseudomembranous colitis Pseudomembranous colitis postmarketing x x x
Body temperature increased Drug fever postmarketing x x x
Renal failure Renal impairment postmarketing x
Renal impairment Renal impairment postmarketing x
Blister Blister x
Dermatitis bullous Blister x
Meningitis Meningitis x
Urinary tract infection Urinary tract infection x
Coombs test positive Coombs test positive x
Blood bilirubin increased Blood bilirubin increased x
Pneumonia streptococcal Pneumonia due to Streptococcus, group b x
Thrombocytosis Thrombocytosis x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CEFIXIME / SUPRAX

Side effects:44
Source:Health Canada

CEFIXIME ANHYDROUS

Side effects:46
Source:FDA Structured Product Label

CEFIXIME ANHYDROUS

Side effects:47
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label